secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001493152-23-025869
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical wins auction for Surgalign's biologics and spinal fixation assets
-------------------------------------------------------------------------------

- Won auction for Surgalign's domestic and international biologics and spinal fixation assets via initial bid from June 18 APA.
- Closing expected after Bankruptcy Court sale hearing on Aug 8, 2023, but no later than Sep 1, 2023.
- CEO Sean Browne expects assets to contribute to growth, complementing earlier Coflex acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223025869/0001493152-23-025869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223025869/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-025869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer